Literature DB >> 30429275

Ultrastructural mechanisms of macrophage-induced demyelination in CIDP.

Haruki Koike1, Ryoji Nishi2, Shohei Ikeda2, Yuichi Kawagashira2, Masahiro Iijima2, Masahisa Katsuno2, Gen Sobue2.   

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a form of chronic neuropathy that is presumably caused by heterogeneous immune-mediated processes. Recent advances in the search for autoantibodies against components expressed at nodal regions, such as the nodes of Ranvier and paranodes, have substantially contributed to clarifying the pathogenesis of CIDP in a subpopulation of patients. In particular, immunoglobulin G4 (IgG4) antibodies to paranodal junction proteins, including neurofascin-155 and contactin-1, have attracted the attention of researchers. Paranodal dissection resulting from the attachment of IgG4 at paranodal junctions and the absence of macrophage-induced demyelination are characteristic pathologic features in patients who have these antibodies. By contrast, the mechanisms of neuropathy in cases with classical macrophage-induced demyelination remain unclear despite the long-standing recognition of this process in CIDP. In addition to complement-dependent damage provoked by autoantibodies, recent studies have shed light on antibody-dependent phagocytosis by macrophages without participation of complements. However, a direct association between specific autoantibodies and macrophage-induced demyelination has not been reported. Electron microscopic examination of longitudinal sections of sural nerve biopsy specimens suggested that macrophages recognize specific sites of myelinated fibers as the initial target of demyelination. The site that macrophages select to initiate myelin breakdown is located around the nodal regions in some patients and internode in others. Hence, it seems that the components that distinguish between the nodal regions and internode play a pivotal role in the behavior of macrophages that initiate phagocytosis of myelin. Further studies are needed to elucidate the mechanisms underlying macrophage-induced demyelination from this perspective.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Year:  2018        PMID: 30429275     DOI: 10.1212/WNL.0000000000006625

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

Authors:  Jolien Wolbert; Mandy I Cheng; Gerd Meyer zu Horste; Maureen A Su
Journal:  JCI Insight       Date:  2020-02-13

Review 2.  Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.

Authors:  Lisha Tang; Qianyi Huang; Zhen Qin; Xiangqi Tang
Journal:  J Neurol       Date:  2020-04-07       Impact factor: 4.849

3.  Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.

Authors:  Juliane Klehmet; Svenja Beutner; Sarah Hoffmann; Matthias Dornauer; Friedemann Paul; Ralf Reilmann; Alexander U Brandt; Andreas Meisel
Journal:  BMC Neurol       Date:  2019-06-08       Impact factor: 2.474

Review 4.  Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Anna Lena Fisse; Jeremias Motte; Thomas Grüter; Melissa Sgodzai; Kalliopi Pitarokoili; Ralf Gold
Journal:  Neurol Res Pract       Date:  2020-12-08

Review 5.  Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.

Authors:  Jun-Ichi Kira
Journal:  Front Neurol       Date:  2021-06-10       Impact factor: 4.003

Review 6.  Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.

Authors:  Hwan Tae Park; Young Hee Kim; Kyung Eun Lee; Jong Kuk Kim
Journal:  Cell Mol Life Sci       Date:  2019-12-28       Impact factor: 9.261

7.  Demyelinating Neuropathy Due to Intravascular Large B-cell Lymphoma.

Authors:  Yuki Fukami; Haruki Koike; Masahiro Iijima; Junichirou Hagita; Hisayoshi Niwa; Ryoji Nishi; Yuichi Kawagashira; Masahisa Katsuno
Journal:  Intern Med       Date:  2019-10-07       Impact factor: 1.271

8.  Feline irradiated diet-induced demyelination; a model of the neuropathology of sub-acute combined degeneration?

Authors:  Abigail B Radcliff; Moones Heidari; Aaron S Field; Ian D Duncan
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

Review 9.  Cytotoxic Immunity in Peripheral Nerve Injury and Pain.

Authors:  Alexander J Davies; Simon Rinaldi; Michael Costigan; Seog Bae Oh
Journal:  Front Neurosci       Date:  2020-02-21       Impact factor: 4.677

Review 10.  Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy.

Authors:  Haruki Koike; Masahisa Katsuno
Journal:  Neurol Ther       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.